Browse by Journal

Jump to: 2026 | 2025 | 2019 | 2018

Number of items: 5.

2026

Melis, Poyraz, Buse, Sari, Jérôme, Ambroise, Melanie, Spears, Martin, Michaelis, Jindrich Jr., Cinatl, Romain, Boidot, Kristian, Serafimov, Olivier, Feron, François P., Duhoux, and others. (2026) Divergent transcriptional programs and constrained metabolic states reveal selective metabolic dependencies in chemoresistant luminal breast cancer. Cancer Drug Resistance, 9 . Article Number 30. ISSN 2578-532X. (doi:10.20517/cdr.2026.57) (KAR id:116171)

Cuprych-Belter, Monika, Łupicka-Słowik, Agnieszka, Anisiewicz, Artur, Michaelis, Martin, Cinatl Jr., Jindrich, Psurski, Mateusz (2025) Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant bladder cancer cell lines. Cancer Drug Resistance, 8 (49). ISSN 2578-532X. (doi:10.20517/cdr.2025.95) (KAR id:111434)

Michaelis, Martin, Wass, Mark N., Cinatl, Jindrich (2019) Drug-Adapted Cancer Cell Lines as Preclinical Models of Acquired Resistance. Cancer Drug Resistance, 2 (3). pp. 447-456. ISSN 2578-532X. (doi:10.20517/cdr.2019.005) (KAR id:76175)

Fenton, Tim R., Garrett, Michelle D., Michaelis, Martin, Wass, Mark N. (2018) Meeting Abstracts of the BACR conference: response and resistance in cancer therapy. Cancer Drug Resistance, 1 . pp. 266-302. E-ISSN 2578-532X. (doi:10.20517/cdr.2018.18) (KAR id:73043)

Fenton, Tim R., Garrett, Michelle D., Wass, Mark N., Michaelis, Martin (2018) What really matters - response and resistance in cancer therapy. Cancer Drug Resistance, 2018 (1). pp. 200-203. ISSN 2578-532X. (doi:10.20517/cdr.2018.19) (KAR id:71006)

This list was generated on Sun Oct 18 02:53:36 2026 BST.